Systematic Review

Published on 24 Nov 2022

Adverse event profiles of adjuvant treatment with opicapone in Parkinson’s disease: A systematic review and meta-analysis

in Neuropharmacology

Luwen Xie
Xiaoyi Qi
Xuan Wang
Bing He
Yu Wang
Wei Zhang
Zehui Yu
Mingming Deng
Sicheng Liang
Muhan Lü

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1042992

2,383 views
2 citations

Original Research

Published on 23 Nov 2022

The differential in vivo contribution of spinal α2A- and α2C-adrenoceptors in tonic and acute evoked nociception in the rat

in Neuropharmacology

Gustavo López-Córdoba
Guadalupe Martínez-Lorenzana
Jair Lozano-Cuenca
Miguel Condés-Lara
Abimael González-Hernández

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1023611

6,529 views
2 citations

Original Research

Published on 23 Nov 2022

Doxycycline attenuates l-DOPA-induced dyskinesia through an anti-inflammatory effect in a hemiparkinsonian mouse model

in Neuropharmacology

Maurício dos Santos Pereira
Glauce Crivelaro do Nascimento
Mariza Bortolanza
Patrick Pierre Michel
Rita Raisman-Vozari
Elaine Del Bel

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1045465

3,142 views
7 citations

Original Research

Published on 23 Nov 2022

AA147 ameliorates post-cardiac arrest cerebral ischemia/reperfusion injury through the co-regulation of the ATF6 and Nrf2 signaling pathways

in Neuropharmacology

Zhu Yuan
Liping Lu
Yingtao Lian
Yuanrui Zhao
Tingting Tang
Song Xu
Zhun Yao
Zhui Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1028002

3,576 views
15 citations

Correction

Published on 18 Nov 2022

Corrigendum: Striatal dopamine D2-muscarinic acetylcholine M1 receptor-receptor interaction in a model of movement disorders

in Neuropharmacology

René A. J. Crans
Elise Wouters
Marta Valle-León
Jaume Taura
Caio M. Massari
Víctor Fernández-Dueñas
Christophe P. Stove
Francisco Ciruela

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1075433

791 views

Original Research

Published on 18 Nov 2022

Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder

in Neuropharmacology

Celine M. Laffont
Eliford Ngaimisi
Mathangi Gopalakrishnan
Vijay Ivaturi
Malcolm Young
Mark K. Greenwald
Christian Heidbreder

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1052113

6,800 views
13 citations

Editorial

Published on 18 Nov 2022

Editorial: Treatment of Alzheimer’s disease-discovery of natural products based on neurite outgrowth and neuroprotection

in Neuropharmacology

Zhiyou Yang
Cai Song
Yue-Wei Ge
Chihiro Tohda

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1079783

1,790 views
1 citation

Review

Published on 18 Nov 2022

Gαs, adenylyl cyclase, and their relationship to the diagnosis and treatment of depression

in Neuropharmacology

Jeffrey M. Schappi
Mark M. Rasenick

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1012778

3,289 views
6 citations

Clinical Trial

Published on 18 Nov 2022

Low-dose naloxone for prophylaxis of sufentanil-induced choking and postoperative nausea and vomiting

in Neuropharmacology

Yiling Qian
Zhifei Huang
Guilong Wang
Jinghong Han
Difei Zhou
Hailei Ding
Xin Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1050847

2,607 views
9 citations

Review

Published on 17 Nov 2022

Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials

in Neuropharmacology

Victoria A. Nazarova
Aleksandr V. Sokolov
Vladimir N. Chubarev
Vadim V. Tarasov
Helgi B. Schiöth

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1066988

56,304 views
25 citations

Original Research

Published on 10 Nov 2022

Neuroprotection of Gastrodia elata polyphenols against H2O2-induced PC12 cell cytotoxicity by reducing oxidative stress

in Neuropharmacology

Weijian Tan
Qinhua Zheng
Kexin Feng
Xiaolin Feng
Wenting Zhong
Caiyu Liao
Shangjian Li
Yuntong Liu
Wenzhong Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1050775

2,805 views
13 citations

Original Research

Published on 09 Nov 2022

A bibliometric analysis of the recent advances in diazepam from 2012 to 2021

in Neuropharmacology

Ming Zhang
Lin Kou
Yaya Qin
Junwen Chen
Dazhang Bai
Li Zhao
Hongyu Lin
Guohui Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1042594

8,072 views
5 citations

Review

Published on 08 Nov 2022

New insights in ferroptosis: Potential therapeutic targets for the treatment of ischemic stroke

in Neuropharmacology

Ziqing Wei
Yi Xie
Mingze Wei
Huijuan Zhao
Kaidi Ren
Qi Feng
Yuming Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1020918

4,753 views
15 citations

Review

Published on 07 Nov 2022

Natural product-based pharmacological studies for neurological disorders

in Neuropharmacology

Vivek Puri
Neha Kanojia
Ameya Sharma
Kampanart Huanbutta
Divya Dheer
Tanikan Sangnim

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1011740

10,184 views
19 citations

Original Research

Published on 04 Nov 2022

A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021

in Neuropharmacology

Liu Liu
Jianxing Liu
Ming Zhao
Meiming Cai
Fanzhang Lei
Xiaofeng Zeng
Bofeng Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.969883

5,138 views
5 citations

Systematic Review

Published on 03 Nov 2022

Neuropharmacological efficacy of metformin for stroke in rodents: A meta-analysis of preclinical trials

in Neuropharmacology

Wenqiao Fu
Yin Tang
Xudong Che
Jiahe Tan
Yinrui Ma
Zhaohui He

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1009169

2,342 views
4 citations

Navigation group

Articles

Adverse event profiles of adjuvant treatment with opicapone in Parkinson’s disease: A systematic review and meta-analysis

The differential in vivo contribution of spinal α2A- and α2C-adrenoceptors in tonic and acute evoked nociception in the rat

Doxycycline attenuates l-DOPA-induced dyskinesia through an anti-inflammatory effect in a hemiparkinsonian mouse model

AA147 ameliorates post-cardiac arrest cerebral ischemia/reperfusion injury through the co-regulation of the ATF6 and Nrf2 signaling pathways

Corrigendum: Striatal dopamine D2-muscarinic acetylcholine M1 receptor-receptor interaction in a model of movement disorders

Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder

Editorial: Treatment of Alzheimer’s disease-discovery of natural products based on neurite outgrowth and neuroprotection

Gαs, adenylyl cyclase, and their relationship to the diagnosis and treatment of depression

Low-dose naloxone for prophylaxis of sufentanil-induced choking and postoperative nausea and vomiting

Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials

Neuroprotection of Gastrodia elata polyphenols against H2O2-induced PC12 cell cytotoxicity by reducing oxidative stress

A bibliometric analysis of the recent advances in diazepam from 2012 to 2021

New insights in ferroptosis: Potential therapeutic targets for the treatment of ischemic stroke

Natural product-based pharmacological studies for neurological disorders

A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021

Neuropharmacological efficacy of metformin for stroke in rodents: A meta-analysis of preclinical trials